Image

Pilot Study of Normative Range of Field of Binocular Single Vision in Adults in Singapore

Pilot Study of Normative Range of Field of Binocular Single Vision in Adults in Singapore

Recruiting
21-59 years
All
Phase N/A

Powered by AI

Overview

The assessment and monitoring of the field of binocular single vision remains a crucial aspect of ophthalmological care, yet current clinical practice relies on normative standards established by Feibel \& Roper-Hall in 1974 that present significant limitations for contemporary application. The original study, conducted with a demographically homogeneous Caucasian population in St Louis using only "several" normal individuals, raises concerns regarding its applicability to Asian populations, particularly in Singapore, where ethnic and genetic factors may influence ocular characteristics. The limited sample size significantly increases the likelihood of Type II errors, whilst the temporal gap of over five decades introduces additional concerns regarding population changes, environmental factors, and advances in measurement techniques that have not been incorporated into current normative data. Given these substantial limitations in demographic representation, statistical power, and temporal relevance, there exists a pressing need to establish population-specific normative data for the field of binocular single vision in Singapore's adult population, which would provide more clinically relevant reference values and potentially improve diagnostic accuracy for ocular conditions in the local context.

Description

The assessment and monitoring of the field of binocular single vision is a crucial aspect of ophthalmological care, particularly in the management of oculoplastics and strabismus. Currently, clinicians worldwide, including those in Singapore, rely on the normal boundary of the field of binocular single vision established by Doctor Robert M. Feibel \& Gill Roper-Hall in 1974 as the gold-standard parameter for clinical assessment. However, this long-standing standard raises several significant concerns regarding its applicability to our current population.

The original study by Feibel \& Roper-Hall was conducted in St Louis, Missouri, United States of America, with participants who were likely of Caucasian descent. This demographic composition presents a potential limitation when applying these standards to Asian populations, particularly in Singapore, where ethnic and genetic factors may influence ocular characteristics. Furthermore, the study's methodology involved only "several" normal individuals, suggesting a sample size of more than two but fewer than ten participants. A sample size of this limited scope significantly increases the likelihood of Type II errors, potentially compromising the statistical power and reliability of the established normative values.

The temporal gap of over five decades since the original study adds another layer of concern. Population characteristics, environmental factors, and lifestyle patterns have undergone substantial changes during this period, potentially affecting ocular health parameters. Additionally, advances in measurement techniques and an understanding of ocular physiology suggest the need for updated normative data that reflect current population characteristics and incorporate modern assessment methodologies.

Given these limitations, there is a pressing need to establish population-specific normative data for the field of binocular single vision in Singapore's adult population. This would not only provide more relevant reference values for clinical assessment but also potentially improve the accuracy of diagnosis and monitoring of various ocular conditions in our local context.

Eligibility

Inclusion Criteria:

  • Age: 21 to 59 years old
  • Gender: Males or females
  • Ethnicity: Asian descent.
  • Language comprehension: Able to understand verbal spoken instructions in:

    • British/American English

    • Mandarin Chinese
    • Bahasa Melayu
  • Protocol compliance: Ability to comply with the study protocol, as determined by the investigator's judgment
  • Consent capacity: Must be able to understand and provide informed consent, with signed informed consent form required before any study assessments

Exclusion Criteria:

\- Communication barrier: Unable to understand verbal spoken instructions

  • Medical history:
    • Any facial trauma
    • Any ocular trauma
    • Any head trauma
    • Any history of ocular disease
    • Any history of ocular surgery
    • Systemic condition(s)
  • Near visual acuity:
    • Right eye \& Left eye monocularly, binocularly unaided near vision: worse than N6 at 40cm from participant's nose
  • Ocular alignment:
    • Prism cover test at near (30cm) of equal or greater than 10 prism diopters at these positions of gaze:
      • Primary gaze
      • Right gaze
      • Left gaze
      • Up gaze
      • Down gaze
  • Extraocular movement:
    • Extraocular movement of over-action or under-action of equal or greater than 0.5 in any of the nine cardinal positions of gaze
  • Confrontational Visual field:
    • Abnormal monocular visual field on confrontational visual field test
  • Hess chart test o Abnormal or asymmetry in pattern of extraocular muscle action in Hess chart test

Study details
    Binocular Visual Function

NCT07257341

Tan Tock Seng Hospital

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.